Bioventus surges on Q3 beats

3 hours ago 1

Bioventus (BVS) is up ~19% in Tuesday trading after posting Q3 financial results that beat on both lines.
While net sales change year-over-year was essentially flat due to a ~29% decline in its restorative therapies segment, the medical device company saw strong growth